TY - JOUR
T1 - Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2
AU - Cenac, Nicolas
AU - Coelho, Anne Marie
AU - Nguyen, Cathy
AU - Compton, Steven
AU - Andrade-Gordon, Patricia
AU - MacNaughton, Wallace K.
AU - Wallace, John L.
AU - Hollenberg, Morley D.
AU - Bunnett, Nigel W.
AU - Garcia-Villar, Rafael
AU - Bueno, Lionel
AU - Vergnolle, Nathalie
N1 - Funding Information:
Supported by grants from the Canadian Institute of Health Research (to N. V., J. L. W., M. D. H.), NicOx S.A. (to N. V.), the Canadian Association of Gastroenterology (to N. V., C. N.), Johnson & Johnson Focused Giving (to J. L. W., M. D. H., N. W. B.), the UPSA Foundation (to N. C., R. G. V., L. B.), the French Institut National de la Recherche Agronomique (to N. C., R. G. V., L. B.), Pfizer Laboratories Fresnes, France (to A. C.), and the National Institutes of Health (grants DK 43207, 57480, 39957 to N. W. B. ).
PY - 2002
Y1 - 2002
N2 - Proteinase-activated receptor (PAR)-2, a G-protein-coupled receptor for trypsin and mast cell tryptase, is highly expressed in the intestine. Luminal trypsin and tryptase are elevated in the colon of inflammatory bowel disease patients. We hypothesized that luminal proteinases activate PAR-2 and induce colonic inflammation. Mice received intracolonically PAR-2 agonists (trypsin, tryptase, and a selective PAR-2-activating peptide) or control drugs (boiled enzymes, inactive peptide) and inflammatory parameters were followed at various times after this treatment. Colonic administration of PAR-2 agonists up-regulated PAR-2 expression and induced an inflammatory reaction characterized by granulocyte infiltration, increased wall thickness, tissue damage, and elevated T-helper cell type 1 cytokine. The inflammation was maximal between 4 and 6 hours and was resolved 48 hours after the intracolonic administration. PAR-2 activation also increased paracellular permeability of the colon and induced bacterial trans-location into peritoneal organs. These proinflammatory and pathophysiological changes observed in wild-type mice were not detected in PAR-2-deficient mice. Luminal proteinases activate PAR-2 in the mouse colon to induce inflammation and disrupt the integrity of the intestinal barrier. Because trypsin and tryptase are found at high levels in the colon lumen of patients with Crohn's disease or ulcerative colitis, our data may bear directly on the pathophysiology of human inflammatory bowel diseases.
AB - Proteinase-activated receptor (PAR)-2, a G-protein-coupled receptor for trypsin and mast cell tryptase, is highly expressed in the intestine. Luminal trypsin and tryptase are elevated in the colon of inflammatory bowel disease patients. We hypothesized that luminal proteinases activate PAR-2 and induce colonic inflammation. Mice received intracolonically PAR-2 agonists (trypsin, tryptase, and a selective PAR-2-activating peptide) or control drugs (boiled enzymes, inactive peptide) and inflammatory parameters were followed at various times after this treatment. Colonic administration of PAR-2 agonists up-regulated PAR-2 expression and induced an inflammatory reaction characterized by granulocyte infiltration, increased wall thickness, tissue damage, and elevated T-helper cell type 1 cytokine. The inflammation was maximal between 4 and 6 hours and was resolved 48 hours after the intracolonic administration. PAR-2 activation also increased paracellular permeability of the colon and induced bacterial trans-location into peritoneal organs. These proinflammatory and pathophysiological changes observed in wild-type mice were not detected in PAR-2-deficient mice. Luminal proteinases activate PAR-2 in the mouse colon to induce inflammation and disrupt the integrity of the intestinal barrier. Because trypsin and tryptase are found at high levels in the colon lumen of patients with Crohn's disease or ulcerative colitis, our data may bear directly on the pathophysiology of human inflammatory bowel diseases.
UR - http://www.scopus.com/inward/record.url?scp=0036840275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036840275&partnerID=8YFLogxK
U2 - 10.1016/S0002-9440(10)64466-5
DO - 10.1016/S0002-9440(10)64466-5
M3 - Article
C2 - 12414536
AN - SCOPUS:0036840275
SN - 0002-9440
VL - 161
SP - 1903
EP - 1915
JO - American Journal of Pathology
JF - American Journal of Pathology
IS - 5
M1 - 64466
ER -